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Aim: To investigate the effect of hypercholesterolemia on in vitro contractions of the detrusor smooth muscle stimulated by an electrical
field in rats and the relative contributions of cholinergic and noncholinergic neurotransmission.
Materials and methods: Sprague-Dawley rats were fed with standard diet (NC group) or with 4% cholesterol diet (HC group). After 4
weeks, the urinary bladder was excised under anesthesia and 4 detrusor strips were prepared. Blood samples were collected for serum
lipid profile, and aortic arches were dissected for histopathological examination. In vitro contractile function of the detrusor smooth
muscle was evaluated with: 1) electrical field stimulation (EFS) only, 2) EFS in the presence of muscarinic antagonist atropine (10–6
M), and 3) EFS in the presence of atropine and P2X antagonist phosphate-6-azo (benzene-2,4-disulfonic acid) tetrasodium salt hydrate
(10–4 M) or P2X agonist α,β-methylene-adenosine-5’-triphosphate (10–5 M).
Results: Plasma cholesterol was elevated in the HC group (P < 0.05); there was no sign of atherosclerosis. Although EFS-induced
contractions were higher in the HC group, the difference was not significant. Cholinergic or purinergic antagonists decreased contractile
response by desensitization with the purinergic agonist. The contribution of cholinergic and purinergic components were also similar
in both groups.
Conclusion: The contribution of cholinergic and noncholinergic mechanisms of neurotransmission seems to be independent of the
high cholesterol content of the diet and the plasma cholesterol level in rat detrusor muscle.
Key words: Cholesterol, cholinergic, urinary bladder, electrical field stimulation, purinergic

1. Introduction
Contraction of the urinary bladder via neural stimulation
is mediated by cholinergic and nonadrenergic
noncholinergic (NANC) mechanisms (1). Acetylcholine
is the main mediator of bladder contraction via activation
of muscarinic receptors (2). The contractile responses
of detrusor strips elicited by electrical stimulation are
not completely abolished by the muscarinic antagonist
atropine. These atropine-resistant contractions are defined
as NANC contractile components (3). The major NANC
component is the purinergic system, which is involved
both in sensory and motor functions of the urinary bladder
(1). ATP released via neural stimulation is reported to be
responsible for the initial rise in intravesical pressure and
initiation of the micturition (4).
The biological properties of cell membranes are closely
related to their cholesterol content. Dietary cholesterol
is one of the sources of membrane cholesterol. Twothirds of the cholesterol in the plasma is carried by low* Correspondence: serkan.karaismailoglu@hacettepe.edu.tr

density lipoprotein (LDL), which provides a source of
cholesterol for the plasma membrane (5). The cholesterolenriched domains of the cell membrane (6) play several
important roles in cellular processes (7,8). They also
provide a platform for G-protein, tyrosine kinase, and
GTPase-mediated signaling in the detrusor membrane
(9,10). Alterations in plasma cholesterol levels are closely
related to membrane cholesterol, which in turn modulates
signaling through the detrusor smooth muscle membrane
(8–11). Based on this knowledge, it is natural to expect
alterations of urinary bladder functions in response to
changing plasma cholesterol.
The effect of hypercholesterolemia on detrusor
contractility has been investigated in a limited number
of studies (12–16). It has been shown that a number
of neurotransmitters released in response to neural
stimulation, which is mainly mediated by the cholinergic
system and in addition by the purinergic system (17),
are likely to be altered under pathological conditions
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(14,18,19). Since urinary bladder dysfunctions are
increasing in incidence, especially in the elderly population
where hypercholesterolemia is also common (20,21), we
aimed to investigate the in vitro contractions of detrusor
smooth muscle strips stimulated by an electrical field and
the cholinergic and noncholinergic neurotransmission in
hypercholesterolemic rats.
2. Materials and methods
The experimental protocol was approved by the Hacettepe
University Institutional Ethics Committee for the Care
and Use of Experimental Animals. Twelve male SpragueDawley rats of 4–7 weeks old were divided into control (n =
6) and cholesterol (n = 6) groups. The control group (NC)
was fed with standard rat chow and the cholesterol group
(HC) was fed with a high cholesterol diet (4% cholesterol
and 0.2% deoxycholate) for 4 weeks (22,23). All rats were
kept in standard conditions (room temperature in a 12-h
light/12-h dark cycle) with free access to food and water.
At the end of 4 weeks, rats were placed in metabolic cages
for 24 h to determine food and water consumption, urine
volume, and weight differences.
The rats were fasted overnight after being removed
from the metabolic cages; the abdomen was then opened
through a midline incision and the urinary bladder was
excised under ether anesthesia. Blood samples were
collected by cardiac puncture for the serum lipid profile.
Aortic arches (1–1.5 cm) were dissected, removed, and
fixed in 10% formalin for histopathological evaluation.
In cold oxygenated Krebs solution, the urinary bladder
was cleared of all the surrounding adipose and connective
tissues and opened up with an incision starting from
the bladder neck. Four longitudinal strips (10 × 2 mm)
were prepared from the bladder body. Each strip was
attached to a tension transducer (MAY FDT 05, Commat,
Ankara, Turkey) and immersed in a 15-mL glass organ
bath containing Krebs–Henseleit solution (118.4 mM
NaCl, 4.7 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4,
25.0 mM NaHCO3, 2.5 mM CaCl2, 12.2 mM glucose; pH
7.35–7.40) gassed with a mixture of 95% O2 and 5% CO2
and maintained at 37 °C under a resting tension of 0.5 g.
Before any experimental procedures, the detrusor strips
were allowed to equilibrate for at least 60 min of washing
with fresh buffer every 15 min. Mechanical activity was
recorded in real time by a data acquisition/analysis system
(BIOPAC MP30, BIOPAC Systems Inc., Goleta, CA, USA).
Each strip was subjected to the following contraction
protocols. One strip was allocated as the time control.
2.1. Contraction protocols
The contraction protocols are summarized in Figure
1. In the first protocol, following equilibration, strips,
suspended between 2 platinum electrodes, were stimulated
by an electrical field stimulation (EFS). A series of square
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Figure 1. Schematic presentation of the experimental protocols
applied to bladder strips: 1) EFS only, 2) EFS in the presence of
atropine (10–6 M), and 3) EFS in the presence of atropine and
PPADS (10–4 M) or α,β-meATP (10–5 M) to study the contraction
of detrusor smooth muscle. Prazosin (10–7 M) was present
throughout the EFS experiments.

wave electrical pulses (0.15 ms pulse width, 100 V tension)
of 5 s in duration was delivered at 3 min intervals (Grass
stimulator; Model S88, Grass Institute, Quincy, MA, USA).
The tension developed at 1, 2, 5, 10, 20, 40, and 80 Hz was
recorded. After determining the frequency of maximal
response, the strips were stimulated at the maximal
response frequency twice at 3-min intervals. The EFS
parameters were determined by modifying the suggestions
of Longhurst and Uvelius (17).
The second protocol was applied after the strips were
reequilibrated. EFS was repeated as described above after
20 min of incubation with muscarinic antagonist atropine
(10–6 M).
In the third protocol, either P2X antagonist phosphate6-azo (benzene-2,4-disulfonic acid) tetrasodium salt
hydrate (PPADS) (10–4 M) (24) or P2X agonist α,βmethylene-adenosine-5’-triphosphate (α,β-meATP) (10–5
M) (25) was added to the bath in the presence of atropine
(10–6 M) to isolate the noncholinergic component of the
parasympathetic stimulation. EFS was repeated after an
incubation period of 40 min for PPADS. α,β-meATP was
administered repeatedly every 10 min to desensitize the
detrusor strips until no contractile response was attained
with the agonist. After 10 min of desensitization, EFS was
repeated.
Prazosin (10–7 M) was present throughout the
experiments to abolish α-adrenergic contractions that
may be generated in response to EFS. In order to identify
if direct stimulation of the detrusor muscle contributes to
the contractile response, 1 µM tetrodotoxin was applied in
the preliminary studies, which abolished all the contractile
response to neural stimulation. Drugs and carriers were
prepared freshly and added directly into the bath in order
to not exceed the volume of the bath by more than 5%.
2.2. Serum lipid profile
Serum lipid profile (total cholesterol, triglyceride, highdensity lipoprotein (HDL), LDL, and very-low-density
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3. Results
Body weight and metabolic cage results were similar
between groups (Table 1). Total cholesterol and LDL
levels were elevated in the cholesterol group compared
with those of the control group (P < 0.05) (Table 2).
Histological evaluation of aortic arch revealed no sign of
atherosclerosis.
The results of first protocol revealed no significant
difference in frequency response curves between the
groups. EFS induced a frequency-dependent increase
in contraction that reached maximum amplitude at
40 Hz stimulation in all detrusor strips. The mean of 3
contraction responses at 40 Hz was 25.1 ± 2.4 g/100 mg

% maximum control response

wet tissue weight in the NC group and 32.9±3.4 g/100 mg
wet tissue weight in the HC group, and it did not achieve
statistical significance.
The contribution of the cholinergic (atropine-sensitive)
component was investigated in the second protocol.
Frequency-response curves after incubation with atropine
and prazosin were reduced in comparison to corresponding
control curves in the NC and HC groups (P < 0.05) (Figure
2); however, there was no significant difference between
groups. The proportion of cholinergic component to EFSinduced contractions increased in relation to frequency
and the highest amplitude of contractions was observed at
40 Hz (38.1 ± 3.0% in the NC group and 36.9 ± 3.4% in the
HC group) (P > 0.05) (Figure 3).
The contribution of the purinergic component was
investigated via receptor blockage (P2X antagonist;
PPADS) or desensitization (P2X agonist; α,β-meATP) in
the third protocol. Desensitization with α,β-meATP was
developed after the second administration. Contractile
activity induced by EFS was significantly decreased in the
presence of PPADS or α,β-meATP (P < 0.05) (Figure 2).
The highest contribution of the purinergic component was

% maximum control response

lipoprotein (VLDL)) was determined by diagnostic kits
using a modular system autoanalyzer (Roche/Hitachi,
Indianapolis, IN, USA) in the Clinical Biochemistry
Laboratory of Hacettepe University Hospital.
2.3. Histopathological evaluation
Buffered formaldehyde (10%) was used to fix aortic arches.
Routine light microscopic tissue processing methods were
employed to process the samples. The sections were stained
with hematoxylin-eosin and evaluated for atherosclerotic
changes (26).
2.4. Drugs
Cholesterol, atropine sulfate, prazosin hydrochloride,
PPADS, and α,β-meATP were purchased from SigmaAldrich (USA) and deoxycholate was purchased from
Merck (Germany). Tetrodotoxin was kindly gifted by
Professor Nuhan Puralı (Department of Biophysics,
Faculty of Medicine, Hacettepe University). All drugs were
dissolved and diluted in distilled water.
2.5. Analysis of data
Data were analyzed by BSL Pro Version 3.6.7 software
(BIOPAC Systems Inc.). The force of contraction was
normalized with wet tissue weight (g/100 mg wet tissue
weight). The number of animals and strips were indicated
by N and n, respectively. The inhibitory effects of drugs
were calculated as the percent of maximal response of
control strips.
Statistical analysis was performed with SPSS 15.0 (SPSS
Inc., Chicago, IL, USA). The general metabolic properties,
weight of the body and urinary bladder, and serum lipid
profiles between groups were compared using Student’s
t-test for independent samples. EFS-induced frequencyresponse curves were compared by repeated measures
analysis of variance (ANOVA) followed by Tukey’s post
hoc test. The effect of drugs was evaluated between groups
at each frequency of EFS with Student’s t-test. All data are
presented as means ± SEM, and n represents the number
of bladder strips. Statistical significance was considered at
the level of P < 0.05.
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Figure 2. Contributions of cholinergic and purinergic components
in contraction response of the rat detrusor smooth muscles to
electrical field stimulation. Frequency-response curves in the
absence (control; N/n= 6/24) and presence of either atropine
(10–6 M; N/n = 6/18) alone or atropine + PPADS (10–4 M; N/n =
6/12) or atropine + α,β-meATP (10–5 M; N/n = 6/6) on bladders
from A) control (NC) and B) cholesterol (HC) groups. The data
are presented as the percentage of the maximum response in the
control strips and values are presented as mean ± SEM.
*: Significantly different compared to the control strips at P <
0.05; †: significantly different compared to atropine-applied
strips at P < 0.05 (applicable for whole curves).
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Table 1. Body weight and metabolic cage results of the control (NC) and cholesterol
(HC) groups.
NC
(N = 6)

HC
(N = 6)

Weight increase (g/4 weeks)

101.7 ± 19.5

141.7 ± 13.3

Food consumption (g/24 h)

20.3 ± 2.5

19.7 ± 2.5

Water consumption (mL/24 h)

43.3 ± 2.1

32.5 ± 3.1

Urine volume (mL/24 h)

16.5 ± 1.3

12.7 ± 0.8

Values are presented as mean ± SEM.
Table 2. Serum lipid profiles of the control (NC) and cholesterol (HC) groups.
NC (mg/dL)
(N = 6)

HC (mg/dL)
(N = 6)

Total cholesterol

95.8 ± 3.7

132.7 ± 9.5*

Triglyceride

35.7 ± 2.0

29.5 ± 2.9

High density lipoprotein

72.8 ± 3.1

72.8 ± 3.1

Low density lipoprotein

28.2 ± 4.3

78.7 ± 9.2*

Very low density lipoprotein

7.1 ± 0.4

5.9 ± 0.6

Values are presented as mean ± SEM. *: Significantly different compared to the control
group at P < 0.05.

4. Discussion
In the present study we investigated the effect of
hypercholesterolemia on the contractile responses in
isolated rat detrusor smooth muscle strips in vitro and
the shares of the cholinergic and purinergic constituents.
Our results indicate that both contractile response to
neural stimulation and contribution of cholinergic and
purinergic components remain relatively unchanged in
hypercholesterolemic rats.
EFS causes stimulation of motor nerve endings
embedded in the detrusor strips and results in frequencydependent contraction. Under physiological conditions,
the cholinergic component that can be eliminated by
atropine has the largest share in detrusor smooth muscle
contractions, and the purinergic component, although
negligible in healthy human bladders, has a considerable
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impact in rats (19,27,28). The studies about the effect
of hypercholesterolemia on detrusor smooth muscle
contractility are limited and conflicting. Increased
contractions in response to carbachol and EFS were
reported in an atherosclerotic rabbit model developed
by a high cholesterol diet (12). On the other hand, in a
recent study, we found no difference in carbachol-induced
contractions in hypercholesterolemic rats (23). Son et al.
(14) showed no difference in the EFS-induced (50 Hz)
contractile response in hypercholesterolemic rats that were

% contribution

observed at 10 Hz in the presence of PPADS (27.4 ± 2.0%
in the NC group, 31.7 ± 3.6% in the HC group) or in the
presence of α,β-meATP (31.8 ± 5% in the NC group, 33.5 ±
2.6% in the HC group) (Figure 3). No significant difference
was observed in terms of the percentage of the purinergic
components between the NC and HC groups.
Frequency response curves obtained from time-control
strips were similar in all protocols both in the NC and the
HC group.

50
45
40
35
30
25
20
15
10
5
0

NC

Cholinergic

HC

Purinergic
(PPADS)

Purinergic
(α,β-meATP)

Figure 3. Contributions of cholinergic and purinergic (in the
presence of PPADS (10–4 M) or α,β-meATP (10–5 M)) components
in contraction response of the rat detrusor smooth muscles to
EFS in the control (NC; N = 6) and cholesterol (HC; N = 6)
groups.
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also atherosclerotic. In line with this, in the present study
we also showed that frequency contraction responses at
all frequencies applied were comparable between groups.
In our study the duration of the high cholesterol diet
was sufficient to increase plasma cholesterol and LDL
without causing atherosclerosis. The contribution of the
cholinergic component in rat detrusor smooth muscle
strips was reported as 42% (19), 47% (28), and 33% (27)
in different studies. Similarly, we measured the cholinergic
component as approximately 40% (field stimulation
at 40 Hz) in both groups. Cholinergic and purinergic
components are reported to change under pathological
conditions affecting detrusor smooth muscles in, for
example, diabetes (19), interstitial cystitis (18), unstable
bladder (29), and overactive bladder (28). Yoshida et al.
reported similar EFS responses in different age groups
in human detrusor smooth muscle, but showed that the
contribution of purinergic neurotransmission increases
with age (30). Son et al. (14) reported no difference in
response to EFS; however, they found a diminished
proportion of the cholinergic component stimulated by
EFS (50 Hz) in hyperlipidemic rats. We did not observe
any difference in the atropine-sensitive nerve-mediated
contractions between the groups in this study.
P2X receptors (mainly P2X1), expressed in
mammalian bladders, are ATP-gated ion channels that
contribute to urinary bladder functions (24,28). Several
studies suggested that PPADS strongly suppresses P2Xpurinoceptor–mediated contractions (25,31,32). α,βmeATP, an ATP analog, is a selective P2X receptor agonist
and resistant to ATPase. Thus, repeated application of
α,β-meATP can desensitize the P2X receptors (24,25). In
the present study, the purinergic component was found to
be as ~30% (field stimulation at 10 Hz) in the presence
of PPADS and ~33% (field stimulation at 10 and 20 Hz)
in response to desensitization with α,β-meATP both in
the NC and the HC group out of ~60% atropine-resistant
contractions. Kennedy et al. showed 50% depression of
atropine-resistant contractions with PPADS in guinea
pig urinary bladder, in support of our results (24).
Son et al. (14) reported an increased proportion of the
purinergic component in the hypercholesterolemic
group. Similarly, although insignificant, we also found an
increase in the contribution of the purinergic component
in the HC group. Rahman et al. (13) reported detrusor

hypertrophy, up-regulation of P2X1, and increased
expression of P2X3 receptors in the urinary bladder of
hyperlipidemic rats compared to control group. These
changes in purinergic receptors may be the possible cause
of bladder overactivity. Since the above-mentioned data
about hypercholesterolemia and detrusor function include
prolonged periods of hypercholesterolemia (13,14),
atherosclerosis, which intervenes with tissue oxygenation
and nutrition, also complicates the picture in some of
the studies (14). The results of these studies are not fully
mirrored in our experimental conditions of 4 weeks of
hypercholesterolemia with no sign of atherosclerosis.
When cholinergic and purinergic components of EFSinduced contractile responses of detrusor smooth muscles
were abolished, there remained a considerable amount
of contraction (33% in NC group, 35% in HC group).
Incomplete desensitization of P2X purinoceptors or
the presence of other purinoceptors in the rat detrusor
smooth muscle (24,33) could be involved in the residual
contractile component together with the other NANC
transmitter(s) released (18,34–36).
Hypercholesterolemia, due to the alterations of
membrane structure and signaling mechanisms in relation
to it, is a good candidate to be listed among the other
pathological conditions (14,18,19) where the share of the
atropine-resistant detrusor smooth muscle contractions is
subject to change. Although the results of this study suggest
no change in neurotransmission in detrusor smooth
muscles in hypercholesterolemic rats, we strongly suggest
further studies in different species and/or longer durations
of hypercholesterolemia, since the role of the purinergic
component in the contraction of the detrusor smooth
muscle, which may have clinical relevance, remains to be
established.
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